OSTEOPOROSIS AND OSTEOARTHRITIS The prefix “osteo” (which means “bone”) is the only thing that osteoporosis and osteoarthritis have in common. Despite the fact that osteoporosis, arthritis and osteoarthritis (a form […]

We are aware of recent media reports that long-term use of bisphosphonates for osteoporosis (sold under the names of Fosamax [alendronate] and Actonel [risedronate]) may be associated with the occurrence […]

SAC Members and Research MD, MSC, FRCPC KristinClemens Dr. Kristin Clemens is a Clinician-Researcher in the Departments of Medicine and Epidemiology and Biostatistics at Western University. She is also the […]

Guideline and Recommendations 2023 Clinical Practice Guideline The 2023 guideline contains 25 recommendations and 10 good practice statements with a focus on exercise, nutrition, fracture risk assessment, treatment and more […]

After rigorous peer review, the Michael Smith Foundation for Health Research (MSFHR) recently awarded the Fraser Health Authority team in British Columbia (BC), a three-year project team grant worth $500,000. […]

As we work to adjust to our new normal during COVID-19, now more than ever, staying fracture-free is critical for anyone with osteoporosis. Healthcare systems are over-stretched, with general recommendations […]

Vitamin D supplementation has recently been evaluated in Switzerland in a small 1 year randomized clinical trial by Bischoff-Ferrari and colleagues. This study compared the effects of two “high” doses […]

How to Minimize the Harmful Effects Of Medications And Other Medical Conditions On Bone Talk To Your Doctor If you are taking any medications or suffer from any medical conditions […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]